SCHEMBL12899409

SCHEMBL12899409

C/C=C1/NC(=O)[C@@H](C)N(Cc2ccccc2)C1=O

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
EHMT2 Q96KQ7 1/20 0.41
SMO Q99835 2/20 0.40
KMT2A Q03164 4/20 0.40
ALDH1A1 P00352 3/20 0.40
KDM4E B2RXH2 1/20 0.40
MAPT P10636 1/20 0.40
PKM P14618 1/20 0.40
HPGD P15428 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
MEN1 O00255 3/20 0.40
TDP1 Q9NUW8 1/20 0.38
LMNA P02545 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C19 P33261 1/20 0.38
ELANE P08246 1/20 0.37
ALOX12 P18054 1/20 0.36
MAPK1 P28482 1/20 0.36
HSD11B1 P28845 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13297796 0.80 EHMT2 (0.49) EHMT2SMOKMT2AALDH1A1MEN1
SCHEMBL14870544 0.74 ALDH1A1 (0.62) KMT2AALDH1A1KDM4EMAPTPKM
SCHEMBL14870547 0.71 ALDH1A1 (0.63) KMT2AALDH1A1KDM4EMAPTPKM
SCHEMBL4597179 0.70 EHMT2 (0.49) EHMT2SMOKMT2AALDH1A1MEN1
SCHEMBL102314 0.70 EHMT2 (0.49) EHMT2SMOKMT2AALDH1A1MEN1
SCHEMBL4187223 0.70 EHMT2 (0.49) EHMT2SMOKMT2AALDH1A1MEN1
SCHEMBL6300356 0.70 EPHX2 (0.55) KMT2AALDH1A1KDM4EMEN1LMNA
SCHEMBL20086223 0.69 SMO (0.49) EHMT2SMOKMT2AALDH1A1KDM4E
SCHEMBL9766496 0.69 MEN1 (0.60) EHMT2SMOKMT2AALDH1A1MAPT
SCHEMBL21563349 0.69 GSK3A (0.53) EHMT2SMOKMT2AALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7879838-B2 Chemokine receptor antagonists used for the treatment of inflammatory diseases, autoimmune diseases, transplant rejection, infectious diseases, drug sensitivity, ophthalmic inflammation, type I diabetes, viral meningitis and tumors SCHERING CORPORATION (US) 2011-02-01 US disclosed
US-7879838-B2 Chemokine receptor antagonists used for the treatment of inflammatory diseases, autoimmune diseases, transplant rejection, infectious diseases, drug sensitivity, ophthalmic inflammation, type I diabetes, viral meningitis and tumors SCHERING CORPORATION (US) 2011-02-01 US disclosed